Highland Capital Management LLC Sells 1,300 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Highland Capital Management LLC reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 107,130 shares of the medical instruments supplier’s stock after selling 1,300 shares during the quarter. Highland Capital Management LLC’s holdings in DENTSPLY SIRONA were worth $3,556,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of XRAY. Norges Bank bought a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $114,207,000. Nuance Investments LLC grew its stake in DENTSPLY SIRONA by 30.4% in the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock worth $412,982,000 after purchasing an additional 2,702,457 shares in the last quarter. Generation Investment Management LLP grew its stake in DENTSPLY SIRONA by 43.4% in the fourth quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock worth $234,830,000 after purchasing an additional 1,998,012 shares in the last quarter. Wellington Management Group LLP grew its stake in DENTSPLY SIRONA by 21.1% in the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after purchasing an additional 1,419,503 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in DENTSPLY SIRONA by 2,959.1% in the first quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock worth $45,584,000 after purchasing an additional 1,328,525 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Robert W. Baird dropped their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research note on Friday, May 3rd. The Goldman Sachs Group dropped their price objective on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a research note on Monday, May 6th. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Piper Sandler reissued a “neutral” rating and issued a $32.00 price objective (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Finally, Needham & Company LLC lowered their target price on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $34.33.

DENTSPLY SIRONA Stock Down 0.7 %

Shares of XRAY traded down $0.18 during midday trading on Friday, hitting $25.53. 2,241,892 shares of the company’s stock traded hands, compared to its average volume of 2,633,604. DENTSPLY SIRONA Inc. has a 1 year low of $23.94 and a 1 year high of $41.65. The firm’s fifty day moving average is $26.66 and its 200-day moving average is $31.03. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $5.30 billion, a price-to-earnings ratio of -58.02, a price-to-earnings-growth ratio of 1.14 and a beta of 1.01.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. During the same quarter in the prior year, the business posted $0.39 EPS. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 2.02 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Stockholders of record on Friday, June 28th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 28th. This represents a $0.64 annualized dividend and a dividend yield of 2.51%. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 3,577 shares of the firm’s stock in a transaction dated Friday, May 31st. The stock was purchased at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the acquisition, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.